The closing bell has rung and now it's time to take stock of the day's market action. A handful of companies from our global marijuana stock database didn't do so well in today's trading. In alphabetical order, here are 3 of the biggest marijuana stock losers in trading on Thursday, July 20th.
AXIM Biotechnologies Inc. (OTC:AXIM)
This morning, AXIM Biotechnologiesannounced that the company has entered into a services agreement with an Israel-based contract research company to conduct a clinical proof of concept study of a CBD and Gabapentin chewing gum product for the treatment of Restless Leg Syndrome. In today's trading, shares of AXIM fell 5.17% on higher than average trading volume. Be sure to check out the company's marijuana stock profile to view custom charts and more recent news regarding AXIM Biotech.
Shares of Abattis Bioceuticalsdropped 3.33% in today's trading on the CSE. The company's OTC Markets symbol closed flat on volume that was more than double the company's 30-day average volume. Earlier this week, Abattis announced that the company's U.S. listed shares have obtained DTC eligibility.
In today's trading session, shares of MassRootsdropped 2.93% on lighter than average volume. Today's losses came without any recent news from the company. Learn more about MassRoots by checking out the company's marijuana stock profile linked above.
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.